MARKET

MEDP

MEDP

Medpace Holdings
NASDAQ
209.00
-6.54
-3.03%
After Hours: 207.78 -1.22 -0.58% 19:36 12/02 EST
OPEN
213.00
PREV CLOSE
215.54
HIGH
213.20
LOW
206.36
VOLUME
262.48K
TURNOVER
0
52 WEEK HIGH
235.72
52 WEEK LOW
126.95
MARKET CAP
6.50B
P/E (TTM)
32.08
1D
5D
1M
3M
1Y
5Y
Is There An Opportunity With Medpace Holdings, Inc.'s (NASDAQ:MEDP) 40% Undervaluation?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Medpace Holdings, Inc...
Simply Wall St. · 11/25 14:37
Encompass Health (EHC) Proposes 50-Bed Hospital in Florida
Encompass Health (EHC) intends to build a 50-bed inpatient rehabilitation hospital in the Daytona Beach area to further amplify its presence in Florida.
Zacks · 11/22 20:17
Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"
Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks · 11/21 17:45
Cardiovascular Systems (CSII) Q1 Earnings Miss, Revenues Top
The launch of the Scoreflex scoring balloon receives a positive response and generates over $1.7 million in sales during the first quarter for Cardiovascular Systems (CSII).
Zacks · 11/11 15:26
Are Robust Financials Driving The Recent Rally In Medpace Holdings, Inc.'s (NASDAQ:MEDP) Stock?
Most readers would already be aware that Medpace Holdings' (NASDAQ:MEDP) stock increased significantly by 36% over the...
Simply Wall St. · 11/11 11:35
BD (BDX) Q4 Earnings and Revenues Beat Estimates, Margins Up
The majority of BD's (BDX) core units witness strong revenue growth in the fiscal fourth quarter.
Zacks · 11/10 16:16
QIAGEN's (QGEN) Q3 Earnings Top Estimates, 2022 View Up
The ongoing double-digit sales growth in the non-COVID product portfolio, a high level of profitability and strong cash flow are the major upsides for QIAGEN (QGEN).
Zacks · 11/10 15:43
STERIS (STE) Q2 Earnings Miss Estimates, Margins Increase
Barring AST, poor reported revenue performance across three of STERIS' (STE) operating segments poses concerns.
Zacks · 11/10 15:31
More
About MEDP
Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. It also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.

Webull offers kinds of Medpace Holdings Inc stock information, including NASDAQ:MEDP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MEDP stock methods without spending real money on the virtual paper trading platform.